PAR PHARMACEUTICAL COMPANIES, INC. Proceeds from Long-Term Debt Issued
PAR PHARMACEUTICAL COMPANIES, INC. reported Proceeds from Long-Term Debt Issued of $422.88 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2015-08-06
- PAR PHARMACEUTICAL COMPANIES, INC. proceeds from issuance of long-term debt for the quarter ending 2015-06-30 was $0.00.
- PAR PHARMACEUTICAL COMPANIES, INC. proceeds from issuance of long-term debt for the quarter ending 2015-03-31 was $422.88M, a 19.54% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. proceeds from issuance of long-term debt for the quarter ending 2014-09-30 was $0.00.
- PAR PHARMACEUTICAL COMPANIES, INC. proceeds from issuance of long-term debt for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month |
|---|---|---|---|
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $422.88M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $422.88M 10-Q · filed 2015-05-11 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-08-06 | $525.54M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $525.54M 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $525.54M 10-Q · filed 2015-05-11 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $55.00M derived: sum of 2 quarters · filed 2014-11-12 | $198.89M 10-Q · filed 2014-11-12 |
| 2013-06-30 | $55.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $198.89M 10-Q · filed 2014-08-11 | |
| 2013-03-31 | $143.89M 10-Q · filed 2014-05-15 |